Hua Su

Hua Su, MD is a Professor in Residence in the Department of Anesthesia at the University of California San Francisco (UCSF). She serves as the Associate Director for the Center for Cerebrovascular Research and Vice Chair of the UCSF Institutional Animal Care and Use Committee. Her work spans molecular and cellular biology with a specific focus on cerebrovascular and cardiovascular research.

Dr. Su's research interests encompass adeno-associated viral vector (AAV)-mediated tissue specific gene transfer, the pathogenesis of cerebrovascular malformation, development of new therapies for ischemic stroke and arteriovenous malformation, and the impact of aging, peripheral injury (such as bone fracture), and innate immune response on stroke recovery. Her work bridges basic science with clinical applications, particularly in understanding how bone fractures exacerbate stroke outcomes and identifying therapeutic targets to improve recovery.

Analysis of her recent publications reveals a strong focus on arteriovenous malformations (AVMs), with particular emphasis on genetic factors like endoglin and ALK1, inflammatory processes, and therapeutic approaches including gene therapy. Her research consistently explores the intersection of vascular biology, neuroinflammation, and recovery mechanisms following cerebrovascular events.

Dr. Su leads a productive research group with numerous publications featuring consistent collaborators who appear to be her trainees and research staff. Her work has significant translational potential, particularly in developing gene therapies for vascular malformations and interventions to improve stroke recovery, especially in the context of comorbid conditions like bone fractures.